Abstract：【Objective】To investigate the correlation between liver function and Th9 cells in peripheral blood of patients with hepatitis B cirrhosis.【Methods】A total of 140 patients with hepatitis B cirrhosis admitted to two hospitals,including 56 patients with compensatory cirrhosis (A group) and 84 patients with decompensated cirrhosis (B group). While 60 healthy people during the same period were selected as the control group. The expression of Th9 cells in peripheral blood and the serum levels of aspartate aminotransferase (AST),alanine aminotransferase (ALT),alkaline phosphatase (ALP),gamma-glutamyl transpeptide (γ-GT) as well as total bilirubin (TBIL) were measured in all three groups.Pearson correlation was used to analyze the correlation between liver function indexes and Th9 cell expression in peripheral blood.【Results】The percentage of Th9 cell subsets in peripheral blood of patients with B group was significantly higher than that of A group and the control group (P<0.05); The percentage of Th9 cell subsets in peripheral blood of A group was significantly higher than that of the control group(P<0.05). Compared with the control group,the levels of AST,ALT,ALP,γ-GT and TBIL in patients with A group and B group were increased (P<0.05),and the above indexes in patients with B group were higher than those in A group(P<0.05). The levels of serum AST,ALT,γ-GT and TBIL in patients with hepatitis B cirrhosis were positively correlated with Th9 cell expression in peripheral blood (r=0.562,0.536,0.574,and 0.504,respectively,P<0.05).【Conclusion】Th9 cells in peripheral blood of patients with hepatitis B cirrhosis are highly expressed,and Th9 cell level is positively correlated with AST,ALT,γ-GT and TBIL,suggesting that Th9 cells may be involved in the development of hepatitis B cirrhosis.
冯琼, 王妮娟. 乙型肝炎肝硬化患者外周血Th9细胞水平与肝功能的相关性分析[J]. 医学临床研究, 2023, 40(5): 703-705.
FENG Qiong, WANG Ni-juan. Correlation Analysis of Peripheral Blood Th9 Cell Level with Liver Function in Patients with Hepatitis B Cirrhosis. JOURNAL OF CLINICAL RESEARCH, 2023, 40(5): 703-705.
[1] 毛重山,殷辉,肖二辉,等. 血清腺苷脱氨酶和T细胞亚群在慢性乙型肝炎中的表达水平及临床意义[J].中华医院感染学杂志,2020,30(5):698-702. [2] JADALI Z. Th9 Cells as a new player in inflammatory skin disorders[J].Iran J Allergy Asthma Immunol,2019,18(2):120-130. [3] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年版)[J].中华实验和临床感染病杂志(电子版),2015,9(5):570-589. [4] 张露,范志芳,刘殿武,等. 1990－2016年中国乙型肝炎引起的肝硬化及其他慢性肝病疾病负担变化趋势分析[J].中华流行病学杂志,2020,41(2):173-177. [5] LI T Y,YANG Y,ZHOU G,et al. Immune suppression in chronic hepatitis B infection associated liver disease:A review[J].World J Gastroenterol,2019,25(27):3527-3537. [6] TEDESCO D,THAPA M,GUMBER S,et al. CD4+ Foxp3+ T cells promote aberrant immunoglobulin G production and maintain CD8+ T-cell suppression during chronic liver disease[J].Hepatology,2017,65(2):661-677. [7] CHANDWASKAR R,AWASTHI A. Emerging roles of Th9 cells as an anti-tumor helper T cells[J].Int Rev Immunol,2019,38(5):204-211. [8] SEK K,CHAN C W,BEAVIS P A,et al. Adoptive transfer of tumor-specific Th9 cells eradicates heterogeneous antigen-expressing tumor cells[J].Cancer Cell,2021,39(12):1564-1566. [9] CHEN J,DING Y,HUANG F,et al. Irradiated whole-cell vaccine suppresses hepatocellular carcinoma growth in mice via Th9 cells[J].Oncol Lett,2021,21(5):409-417. [10] LU Y,WANG Q,XUE G,et al. Th9 cells represent a unique subset of CD4+ T cells endowed with the ability to eradicate advanced tumors[J].Cancer Cell,2018,33(6):1048-1060. [11] 杜科业,杨东亮,刘嘉. 慢性乙型肝炎与调节性T细胞研究进展[J].实用肝脏病杂志,2019,22(5):613-616. [12] REN M,LI J,XUE R,et al. Liver function and energy metabolism in hepatocellular carcinoma developed in patients with hepatitis B-related cirrhosis[J].Medicine (Baltimore),2019,98(19):15528-15534. [13] BERTOLETTI A,LE BERT N. Immunotherapy for chronic hepatitis B virus infection[J].Gut Liver,2018,12(5):497-507.
2023, Vol. 40 
